Methods and compositions for treating ocular disorders
AssigneeChildren's Medical Center Corporation
InventorLarry I. Benowitz
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for treating and/or preventing damage to a retina or optic nerve in a subject comprising administering to the subject a therapeutically effective amount of oncomodulin. Preferably, the subject is a mammal, most preferably, a human. In preferred embodiments, the oncomodulin may be used in combination with mannose, a mannose derivative and/or inosine.
Claims17
A method for treating and/or preventing damage to a retina or optic nerve in a subject comprising administering to the subject a therapeutically effective amount of oncomodulin.
An article of manufacture comprising packaging material and a pharmaceutical agent contained within said packaging material, wherein said packaging material comprises a label which indicates said pharmaceutical may be administered, for a sufficient term at an effective dose, for treating and/or preventing damage to a retina or optic nerve together with a pharmaceutically acceptable carrier, wherein the pharmaceutical agent comprises a oncomodulin.
A pharmaceutical kit for the treatment and/or prevention of damage to a retina or optic nerve comprising the combination of:
- (a) oncomodulin;
- (b) an axogenic factor;
- and
- (c) a cAMP modulator.
Dependencies are inferred from the claim text.